Transgenic expression of mylpfa:myf5, a transgene that drives myf5 expression in terminally differentiated, myosin light chain 11 (mylpfa) expressing cells, resulted in higher penetrance of rag2-kRASG12D tumor formation (Tenente et al., 2017). The gene discussed is RAG2; the disease is neoplasm.